| 10009286 |
(±)14(15)-EET-SI
|
|
218461-97-3 |
≥95%
|
|
|
2007-05-14
|
15.116151012891
|
-14-15-eet-si
|
(±)14(15)-EET-sulfonimide; (±)14(15)-EpETrE-SI
|
arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF |
15.116151012891
|
| 10005188 |
DAUDA
|
|
73025-02-2 |
≥98%
|
|
|
2007-05-17
|
0.539875562718
|
dauda
|
11-(Dansylamino)undecanoic Acid
|
fluorescent fatty acids S. mansoni Schistosoma mansoni Sm14 fluorescence 11-(dansylamino)undecanoic binding proteins |
0.539875562718
|
| 10009547 |
FABP1 (human recombinant)
Exclusive |
|
- |
>90%
|
|
✓ |
2007-09-04
|
9.086550030693
|
fabp1-human-recombinant
|
Liver-FABP; L-FABP; Fatty Acid Binding Protein
|
proteins metabolism cellular membranes FABP-1 FABPs fatty acids bladders carcinoma renal failure LFABP livers kidneys atherosclerosis endocrinology |
9.086550030693
|
| 10005200 |
FABP1 (rat recombinant)
|
|
- |
>95%
|
|
|
2005-07-29
|
8.036243093922
|
fabp1-rat-recombinant
|
Liver-Fatty Acid Binding Protein; Fatty Acid Binding Protein 1; Liver-FABP; L-FABP
|
protein-only proteins cytosolic fatty acids antiparallel .beta. strands barrel expression hepatoblastoma hepatocellular carcinomas tumors markers liver kidney injury fluorescence displacement assay fluorescent analogue 11-(Dansylamino)undecanoic DAUDA arachidonic oleic pocket atherosclerosis endocrinology |
8.036243093922
|
| 10009548 |
FABP2 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-02-24
|
11.600856353590
|
fabp2-human-recombinant
|
Intestinal-FABP; Fatty Acid Binding Protein 2; I-FABP
|
cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology |
11.600856353590
|
| 10010019 |
FABP2 Polyclonal Antibody
|
|
- |
|
|
|
2007-10-02
|
22.575615627466
|
fabp2-polyclonal-antibody
|
Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2; I-FABP
|
WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting |
22.575615627466
|
| 10007938 |
FABP2 (rat recombinant)
|
|
- |
>95%
|
|
|
2005-12-16
|
7.580699815837
|
fabp2-rat-recombinant
|
Fatty Acid Binding Protein 2; I-FABP; Intestinal-FABP
|
protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology |
7.580699815837
|
| 10007432 |
FABP3 (human recombinant)
|
|
- |
>95%
|
|
|
2005-07-27
|
26.273862799262
|
fabp3-human-recombinant
|
Heart-FABP; Fatty Acid Binding Protein-3; H-FABP
|
protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology |
26.273862799262
|
| 10233 |
FABP3 Monoclonal Antibody (Clone CC68)
|
|
- |
|
|
|
2009-03-20
|
8.984487415591
|
fabp3-monoclonal-antibody-clone-cc68
|
Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP
|
antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting |
8.984487415591
|
| 10009549 |
FABP4 (human recombinant)
|
|
- |
>90%
|
|
|
2007-06-15
|
30.360148746281
|
fabp4-human-recombinant
|
A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein
|
cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology |
30.360148746281
|
| 9001068 |
FABP4 (human recombinant) FITC conjugated
New |
|
- |
≥95%
|
|
|
2011-08-23
|
11.593022888713
|
fabp4-human-recombinant-fitc-conjugated
|
ALBP; Adipocyte-Fatty Acid Binding Protein; FABP4; A-FABP
|
fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 |
11.593022888713
|
| 10010463 |
FABP4 (human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-10-23
|
5.106180939226
|
fabp4-human-recombinant-western-ready-control
|
Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting |
5.106180939226
|
| 10010231 |
FABP4 Inhibitor/Ligand Screening Assay Kit
|
|
- |
|
|
|
2007-11-01
|
23.683769655758
|
fabp4-inhibitor-ligand-screening-assay-kit
|
aP2; Adipocyte FABP; A-FABP; Fatty Acid Binding Protein 4
|
fabps kits atherosclerosis assays fatty acid binding protein adipocytes aP2 cytosolic lipophilic ligands uptake metabolisms cellular membranes intracellular trafficking cells growth differentiation PPARg PPARgamma PPAR.gamma. peroxisomes proliferator-activated receptors agonists insulin genes deletion mice mouse murine chronic metabolic diseases diabetes atherosclerosis fluorescence fluorescent fluorometric endocrinology |
23.683769655758
|
| 10005191 |
FABP4 (mouse recombinant)
|
|
- |
>95%
|
|
|
2005-07-27
|
10.065867403314
|
fabp4-mouse-recombinant
|
Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP
|
protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology |
10.065867403314
|
| 10009676 |
FABP4 (mouse recombinant) Western Ready Control
|
|
- |
|
|
|
2007-04-30
|
4.295814917127
|
fabp4-mouse-recombinant-western-ready-control
|
ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP
|
fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis |
4.295814917127
|
| 10010364 |
FABP5 (human recombinant)
|
|
- |
>95%
|
|
|
2007-08-08
|
16.979712707182
|
fabp5-human-recombinant
|
Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP
|
proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology |
16.979712707182
|
| 10007433 |
FABP5 (mouse recombinant)
|
|
- |
>95%
|
|
|
2005-07-29
|
6.411692616775
|
fabp5-mouse-recombinant
|
Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP
|
protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry |
6.411692616775
|
| 10009551 |
FABP7 (human recombinant)
|
|
- |
>90%
|
|
|
2007-06-27
|
4.380059498512
|
fabp7-human-recombinant
|
B-FABP; Brain-FABP; Fatty Acid Binding Protein 7
|
cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology |
4.380059498512
|
| 700310 |
Free Fatty Acid Assay Kit
|
|
- |
|
|
|
2010-09-08
|
109.454098904597
|
free-fatty-acid-assay-kit
|
FFA
|
kits assays measures measurements acids triglycerides intestines hydrolyzed glycerols enzymes pancreas pancreatic lipases intestinal liposomes capillaries lymph systems blood plasmas serums hepatocytes adipocytes muscles fibers oxidized sugars glucagon fats proteins albumin FFA skeletal skeletons hearts livers pathophysiological obesity insulin resistance type 2 II diabetes pathogenesis insulin-stimulated peripheral glucose uptake beta cells oxidative stressproinflammatory effects NFκB nuclear factors inflammation resistances metabolic urine enzymatic reactions Acyl CoA synthetase ACS acylation coenzymes oxidases ACOD hydrogen peroxides H2O2 horseradish peroxidases HRP 10-aceyl-3,7-dihydroxyphenozazine ADHP fluorescence fluorescent resorufins |
109.454098904597
|
| 10699 |
HTS 01037
|
|
682741-29-3 |
≥98%
|
|
|
2011-03-14
|
15.947182320442
|
hts-01037
|
|
adipocytes fatty acids binding proteins FABP4 AFABP A-FABP aP2 macrophages lipocytes diabetes atherosclerosis HTS-01037 HTS01037 Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid
Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases |
15.947182320442
|
| 10009754 |
Serum Retinol Binding Protein Western Ready Control
Exclusive |
|
- |
|
|
✓ |
2008-07-08
|
0E-12
|
serum-retinol-binding-protein-western-ready-control
|
sRBP4; RBP4
|
proteins C-terminal western blots immunoblotting WB SRBPs hexahistidine His-tag His-tagged insulin resistance tyep 2 diabetes pathogenesis blotting |
0E-12
|